Directory
>
Kai-Hsin Chang
Kai-Hsin Chang
Vice President, Discovery | Editas Medicine
Cambridge, Massachusetts, United States
Kai-Hsin Chang
Summary
Kai-Hsin Chang is a driven and accomplished drug developer specializing in cell and gene therapy research. With a Ph.D. in Parasitology from McGill University, he has built a robust career at Editas Medicine, where he currently serves as Vice President of Discovery. His expertise spans a wide range of areas including molecular biology, stem cell therapies, and genome editing technologies. Notably, he has led multiple teams in the development of groundbreaking therapies for beta hemoglobinopathies and solid tumors. His leadership has been instrumental in successfully navigating drug development from early discovery stages through to regulatory submissions. Outside of his technical skills, Kai-Hsin is known for his strategic thinking and ability to foster collaboration across diverse teams. He is passionate about advancing the frontiers of biotechnology and is committed to addressing unmet medical needs through innovative solutions.
Kai-Hsin Chang
Work Experience
Vice President, Discovery at
Editas Medicine
February 2024 - Present
Vice President, Translational Sciences at
Editas Medicine
February 2023 - January 2024
Vice President, Stem Cell Therapies at
Editas Medicine
March 2022 - January 2023
Senior Director, Ex vivo Pharmacology/Biological Development at
Editas Medicine
April 2021 - March 2022
Director, Ex vivo Pharmacology/Biological Development at
Editas Medicine
April 2019 - April 2021
Associate Director, Preclinical Science at
Editas Medicine
January 2017 - March 2019
Senior Scientist, Cell and Gene Therapy at
Biogen
September 2014 - January 2017
Research Assistant Professor, Hematology at
University of Washington, LLC
September 2013 - September 2014
Acting Assistant Professor, Hematology at
University of Washington, LLC
April 2010 - August 2013
Acting Instructor, Hematology at
University of Washington, LLC
April 2007 - March 2010
Postdoctoral Researcher at
University of Washington, LLC
November 2003 - March 2007
Kai-Hsin Chang
Education
McGill University, Doctor Of Philosophy (Ph.D.)
January 1997 - January 2003
Frequently Asked Questions about Kai-Hsin Chang
What is Kai-Hsin Chang email address?
Kai-Hsin Chang's primary email address is *****@editasmedicine.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kai-Hsin Chang work for?
Kai-Hsin Chang is a Vice President, Discovery at Editas Medicine, a company specializing in Commercial physical research.
Where Kai-Hsin Chang graduated from?
Kai-Hsin Chang holds a degree in Parasitology from McGill University.
How can I directly contact Kai-Hsin Chang?
To contact Kai-Hsin Chang directly, you can use the email address *****@editasmedicine.com. Complete contact information is available upon registration with Muraena.
Who is Kai-Hsin Chang?
Kai-Hsin Chang is a driven and accomplished drug developer specializing in cell and gene therapy research. With a Ph.D. in Parasitology from McGill University, he has built a robust career at Editas Medicine, where he currently serves as Vice President of Discovery. His expertise spans a wide range of areas including molecular biology, stem cell therapies, and genome editing technologies. Notably, he has led multiple teams in the development of groundbreaking therapies for beta hemoglobinopathies and solid tumors. His leadership has been instrumental in successfully navigating drug development from early discovery stages through to regulatory submissions. Outside of his technical skills, Kai-Hsin is known for his strategic thinking and ability to foster collaboration across diverse teams. He is passionate about advancing the frontiers of biotechnology and is committed to addressing unmet medical needs through innovative solutions.
Kai-Hsin`s contact details
*****@editasmedicine.com
Colleagues
Senior Vice President Information Technology
President and CEO
Executive Vice President, Chief Technical and Quality Officer
Vice President of Chemistry & Boulder Site Head
Senior Vice President, Technical Development
Vice President of Financial Planning Analysis
Vice President, Head of Biometrics
Senior Vice President, Corporate Communications and Investor Relations
Senior Vice President, Deputy General Counsel & Asst. Secretary
Vice President, Head of Clinical Operations